Photocure ASA
Develops photodynamic pharmaceuticals and devices to enhance bladder cancer detection for urologists.
PHO | OL
Overview
Corporate Details
- ISIN(s):
- NO0010000045
- LEI:
- 5967007LIEEXZXG8OW35
- Country:
- Norway
- Address:
- HOFFSVEIEN 4, 0275 OSLO
- Website:
- https://www.photocure.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Photocure ASA is a specialty pharmaceutical company, self-described as 'The Bladder Cancer Company.' It develops and commercializes pharmaceuticals and medical devices based on its proprietary photodynamic technology platform. The company's core focus is on improving the diagnosis, treatment, and management of bladder cancer. Its flagship products, marketed as Hexvix® and Cysview®, are used in conjunction with Blue Light Cystoscopy to enhance the visualization and detection of cancerous tumors. Photocure targets the global urologic oncology community, including hospitals, clinics, and specialists, providing transformative solutions to improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-15 17:08 |
Regulatory News Service
Photocure and Intelligent Scopes Corporation partner on development of AI for b…
|
English | 176.1 KB | ||
| 2025-10-15 17:08 |
Regulatory News Service
Photocure and Intelligent Scopes Corporation partner on development of AI for b…
|
English | 11.6 KB | ||
| 2025-09-22 08:23 |
Director's Dealing
Photocure ASA - Share option grant - Attachment: 20250922_PHO_Primary_insider_n…
|
English | 110.6 KB | ||
| 2025-09-22 08:23 |
Remuneration Information
Photocure ASA - Share option grant - Attachment: Release.pdf
|
English | 136.2 KB | ||
| 2025-09-22 08:23 |
Remuneration Information
Photocure ASA - Share option grant
|
English | 2.7 KB | ||
| 2025-08-04 14:39 |
Regulatory News Service
Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review - A…
|
English | 161.4 KB | ||
| 2025-08-04 14:39 |
Regulatory News Service
Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review
|
English | 4.1 KB | ||
| 2025-07-22 08:00 |
Report Publication Announcement
Photocure ASA: Invitation to presentation of second quarter and first half year…
|
English | 117.4 KB | ||
| 2025-07-22 08:00 |
Report Publication Announcement
Photocure ASA: Invitation to presentation of second quarter and first half year…
|
English | 2.5 KB | ||
| 2025-06-23 14:55 |
Director's Dealing
Photocure ASA - Share option grant - Attachment: PHO_OSE_Primary_insider_notifi…
|
English | 161.3 KB | ||
| 2025-06-23 14:55 |
Remuneration Information
Photocure ASA - Share option grant - Attachment: Release.pdf
|
English | 138.0 KB | ||
| 2025-06-23 14:55 |
Remuneration Information
Photocure ASA - Share option grant
|
English | 3.5 KB | ||
| 2025-05-08 05:00 |
Investor Presentation
Photocure ASA: Results for the first quarter of 2025
|
English | 1.2 MB | ||
| 2025-05-08 05:00 |
Quarterly Report
Photocure ASA: Results for the first quarter of 2025
|
English | 742.5 KB | ||
| 2025-05-08 05:00 |
Earnings Release
Photocure ASA: Results for the first quarter of 2025
|
English | 151.0 KB |
Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Photocure ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Photocure ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
